135 related articles for article (PubMed ID: 29600375)
1. Epigenetics: DNA Methylation Analysis in Esophageal Adenocarcinoma.
Islam F; Tang JC; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():247-256. PubMed ID: 29600375
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
3. DNA Genome Sequencing in Esophageal Adenocarcinoma.
Pillai S; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():231-246. PubMed ID: 29600374
[TBL] [Abstract][Full Text] [Related]
4. Targeted Single Gene Mutation in Esophageal Adenocarcinoma.
Lee KTW; Smith RA; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():213-229. PubMed ID: 29600373
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics in the Pathogenesis of Esophageal Adenocarcinoma.
Kailasam A; Mittal SK; Agrawal DK
Clin Transl Sci; 2015 Aug; 8(4):394-402. PubMed ID: 25388215
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM).
Guilleret I; Losi L; Chelbi ST; Fonda S; Bougel S; Saponaro S; Gozzi G; Alberti L; Braunschweig R; Benhattar J
Biochem Biophys Res Commun; 2016 Oct; 479(2):231-237. PubMed ID: 27634218
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of O6-Methylguanine-DNA Methyltransferase (MGMT) promotor hypermethylation in esophageal adenocarcinoma.
Baumann S; Keller G; Pühringer F; Napieralski R; Feith M; Langer R; Höfler H; Stein HJ; Sarbia M
Int J Cancer; 2006 Jul; 119(2):264-8. PubMed ID: 16477636
[TBL] [Abstract][Full Text] [Related]
8. Somatic DNA Copy-Number Alterations Detection for Esophageal Adenocarcinoma Using Digital Polymerase Chain Reaction.
Lee KTW; Gopalan V; Lam AK
Methods Mol Biol; 2018; 1756():195-212. PubMed ID: 29600372
[TBL] [Abstract][Full Text] [Related]
9. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
Kaz AM; Grady WM; Stachler MD; Bass AJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
[TBL] [Abstract][Full Text] [Related]
10. Whole Genome Methylation Analysis of Nondysplastic Barrett Esophagus that Progresses to Invasive Cancer.
Dilworth MP; Nieto T; Stockton JD; Whalley CM; Tee L; James JD; Noble F; Underwood TJ; Hallissey MT; Hejmadi R; Trudgill N; Tucker O; Beggs AD
Ann Surg; 2019 Mar; 269(3):479-485. PubMed ID: 29384778
[TBL] [Abstract][Full Text] [Related]
11. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
[TBL] [Abstract][Full Text] [Related]
12. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of microRNA-193b in human Barrett's esophagus and esophageal adenocarcinoma.
Lü L; Liu T; Gao J; Zeng H; Chen J; Gu X; Mei Z
Mol Med Rep; 2016 Jul; 14(1):283-8. PubMed ID: 27176876
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma.
Brock MV; Gou M; Akiyama Y; Muller A; Wu TT; Montgomery E; Deasel M; Germonpré P; Rubinson L; Heitmiller RF; Yang SC; Forastiere AA; Baylin SB; Herman JG
Clin Cancer Res; 2003 Aug; 9(8):2912-9. PubMed ID: 12912936
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of cysteine dioxygenase type 1 methylation in Barrett esophagus adenocarcinoma.
Kojima K; Yamashita K; Ushiku H; Katoh H; Ishii S; Tanaka T; Yokoi K; Suzuki M; Ooizumi Y; Igarashi K; Hosoda K; Moriya H; Mieno H; Katada N; Tanabe S; Watanabe M
Dis Esophagus; 2017 Mar; 30(3):1-9. PubMed ID: 28184414
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation analysis of germ cells by using bisulfite-based sequencing methods.
Kobayashi H; Kono T
Methods Mol Biol; 2012; 825():223-35. PubMed ID: 22144248
[TBL] [Abstract][Full Text] [Related]
18. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.
Eads CA; Lord RV; Kurumboor SK; Wickramasinghe K; Skinner ML; Long TI; Peters JH; DeMeester TR; Danenberg KD; Danenberg PV; Laird PW; Skinner KA
Cancer Res; 2000 Sep; 60(18):5021-6. PubMed ID: 11016622
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic patterns in the progression of esophageal adenocarcinoma.
Eads CA; Lord RV; Wickramasinghe K; Long TI; Kurumboor SK; Bernstein L; Peters JH; DeMeester SR; DeMeester TR; Skinner KA; Laird PW
Cancer Res; 2001 Apr; 61(8):3410-8. PubMed ID: 11309301
[TBL] [Abstract][Full Text] [Related]
20. Reprimo methylation is a potential biomarker of Barrett's-Associated esophageal neoplastic progression.
Hamilton JP; Sato F; Jin Z; Greenwald BD; Ito T; Mori Y; Paun BC; Kan T; Cheng Y; Wang S; Yang J; Abraham JM; Meltzer SJ
Clin Cancer Res; 2006 Nov; 12(22):6637-42. PubMed ID: 17121882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]